EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases

Kamila Łuczyńska, Zhengwen Zhang, Tadeusz Pietras, Yiguo Zhang, Hiroaki Taniguchi

Redox Biology · 2024-02 · 69 · 103003

DOI: 10.1016/j.redox.2023.103003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Redox Biology, 2024-02. Verfasst von Kamila Łuczyńska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, 05-552, Poland; The Second Department of Psychiatry, I…. Hauptthemen laut MEDLINE: Gene Expression Regulation, Neurodegenerative Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, NCN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The failure of the proper protein turnover in the nervous system is mainly linked to a variety of neurodegenerative disorders. Therefore, a better understanding of key protein degradation through the ubiquitin-proteasome system is critical for effective prevention and treatment of those disorders. The proteasome expression is tightly regulated by a CNC (cap'n'collar) family of transcription factors, amongst which the nuclear factor-erythroid 2-like bZIP factor 1 (NFE2L1, also known as Nrf1, with its long isoform TCF11 and short isoform LCR-F1) has been identified as an indispensable regulator of the transcriptional expression of the ubiquitin-proteasome system. However, much less is known about how the pivotal role of NFE2L1/Nrf1, as compared to its homologous NFE2L2 (also called Nrf2), is translated to its physiological and pathophysiological functions in the nervous system insomuch as to yield its proper cytoprotective effects against neurodegenerative diseases. The potential of NFE2L1 to fulfill its unique neuronal function to serve as a novel therapeutic target for neurodegenerative diseases is explored by evaluating the hitherto established preclinical and clinical studies of Alzheimer's and Parkinson's diseases. In this review, we have also showcased a group of currently available activators of NFE2L1, along with an additional putative requirement of this CNC-bZIP factor for healthy longevity based on the experimental evidence obtained from its orthologous SKN1-A in Caenorhabditis elegans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression RegulationNeurodegenerative DiseasesAnimalsHumansProteasome Endopeptidase ComplexProtein IsoformsCaenorhabditis elegansUbiquitinsNF-E2-Related Factor 1

Stichwörter der Autor:innen

CNCNFE2L1(Nrf1)NFE2L2(Nrf2)NeuroprotectionSKN-1neurodegenerative diseases

Substanzen

Proteasome Endopeptidase ComplexProtein IsoformsUbiquitinsNFE2L1 protein, humanNF-E2-Related Factor 1

Autor:innen und Institutionen

  • Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, 05-552, Poland; The Second Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, 02-957, Warsaw, Poland.
  • Laboratory of Neuroscience, Institute of Cognitive Neuroscience and School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, England, United Kingdom.
  • The Second Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, 02-957, Warsaw, Poland; Department of Clinical Pharmacology, Medical University of Lodz, 90-153, Łódź, Poland.
  • Chongqing University Jiangjin Hospital, School of Medicine, Chongqing University, No. 725 Jiangzhou Avenue, Dingshan Street, Jiangjin District, Chongqing, 402260, China; The Laboratory of Cell Biochemistry and Topogenet…
  • Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences, Jastrzebiec, 05-552, Poland. Electronic address: h.taniguchi@igbzpan.pl.

Förderung

  • National Natural Science Foundation of China
  • NCN

Zitieren

APA

Łuczyńska, K., Zhang, Z., Pietras, T., Zhang, Y., & Taniguchi, H. (2024). NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. Redox Biology, 69, 103003. https://doi.org/10.1016/j.redox.2023.103003

Vancouver

Łuczyńska K, Zhang Z, Pietras T, Zhang Y, Taniguchi H. NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases. Redox Biology. 2024;69:103003. doi:10.1016/j.redox.2023.103003

BibTeX
@article{uczyska2024,
  author = {Łuczyńska, Kamila and Zhang, Zhengwen and Pietras, Tadeusz and Zhang, Yiguo and Taniguchi, Hiroaki},
  title = {NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases},
  journal = {Redox Biology},
  year = {2024},
  volume = {69},
  pages = {103003},
  doi = {10.1016/j.redox.2023.103003}
}
Kostenlos starten →